The eyedrops Larkin and his team developed contain a synthetic peptide that acts to block the pathways which cause the ...

Picture a horse running across an open field, the wind blowing his mane, his hooves stamping into the grassy knoll, eyes on ...

Research in horses may eventually lead to a treatment for people who develop blindness as a result of the autoimmune disease ...

These findings contribute to a better understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases. Each year, approximately 600 Finns are diagnosed ...

These findings contribute to a better understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases. Each year, approximately 600 Finns are diagnosed ...

13 A further example is that CD6-ADC has demonstrated promise in treating two preclinical models of autoimmune uveitis and a humanized model of GVHD, indicating that CD6-ADC may be developed even ...

These findings contribute to a better understanding of the mechanisms behind anterior uveitis and its connection to common autoimmune diseases. Each year, approximately 600 Finns are diagnosed ...

Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...

Acelyrin has punted the autoimmune drug prospect izokibep back ... which it scored a phase 2b/3 win earlier in 2024—to leave uveitis as its last remaining area of active izokibep development.